Does PAZOPANIB Cause Malignant neoplasm progression? 1,471 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,471 reports of Malignant neoplasm progression have been filed in association with PAZOPANIB (Pazopanib). This represents 6.9% of all adverse event reports for PAZOPANIB.
1,471
Reports of Malignant neoplasm progression with PAZOPANIB
6.9%
of all PAZOPANIB reports
570
Deaths
372
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PAZOPANIB?
Of the 1,471 reports, 570 (38.7%) resulted in death, 372 (25.3%) required hospitalization, and 69 (4.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 1,471 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
Disease progression (739)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PAZOPANIB Alternatives Have Lower Malignant neoplasm progression Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS